Pancreatitis in Acute Promyelocytic Leukemia: Drug-induced or Differentiation Syndrome?

Acute promyelocytic leukemia (APL) constitutes about 15% of all acute myeloid leukemia patients and can now be treated even without any chemotherapy, with all-trans-retinoic acid (ATRA) and arsenic trioxide (ATO). Acute pancreatitis (AP) is a rare adverse event in APL, which is primarily reported to...

Descripción completa

Detalles Bibliográficos
Autores principales: De, Dibyendu, Nath, Uttam Kumar, Chakrabarti, Prantar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686987/
https://www.ncbi.nlm.nih.gov/pubmed/29200694
http://dx.doi.org/10.4103/ijmpo.ijmpo_36_16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686987/
https://www.ncbi.nlm.nih.gov/pubmed/29200694
http://dx.doi.org/10.4103/ijmpo.ijmpo_36_16

Ejemplares similares